Leadership U.S. Locations How We Operate Governance Transparency Ethics and Code of Conduct Transparency Our Commitment We value the relationships and partnerships we’ve formed over the years at Gilead. And we will remain transparent about our research and business practices — in order to honor and retain the trust and respect of every one of our customers, partners and employees. As part of our continued dedication to transparency, we proactively disclose and disseminate information regularly through our website, in stakeholder discussions and through our broad outreach in the following areas: Cookie Notice We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them byclicking here. Cookies Settings Disable Cookies Accept All Cookies

Events Stories Newsroom Press Releases Media Inquiries Company Statements Press Releases November 19, 2021 Gilead Submits Biologics License Application to U.S. Food and Drug Administration for Bulevirtide, an Investigational Treatment for People Living With Chronic Hepatitis Delta -- If Approved, Bulevirtide Will Be the First Treatment Option for Adult Patients in the U. S. With Chronic Hepatitis Delta Virus Infection With Compensated Liver Disease -- CLOSE × Welcome Some content on this site is not intended for people outside the United States. ACCEPT Cookie Notice We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them byclicking here. Cookies Settings Disable Cookies Accept All Cookies

Medicines Pipeline Research Research Scholars Program Compassionate Use Investigator-Sponsored Research Mission Statement Gilead Sciences actively supports research efforts conducted by third parties on Gilead's marketed products or within therapeutic areas of interest to the company. This research can provide valuable information regarding the safety, efficacy, pharmacology, and tolerability of Gilead's products and supplement the comprehensive data generated in registration studies. Gilead supports research through either the or , which focus on specific populations and topics. If you are interested in applying for support for your research, please see below for further instructions. Cookie Notice We use cookies to offer you a better browsing experience, analyze site traffic, personalize content, and serve targeted advertisements. Read about how we use cookies and how you can control them byclicking here. Cookies Settings Disable Cookies Accept All Cookies